annual meeting program - American Society of Clinical Oncology

Sunday, June 6, 2010
Brd. 23F Multimodal management of locally advanced (N2) non-small cell lung cancer
(NSCLC): Is there a role for surgical resection? A single institution
experience. (Abstract #7064)
J. Bosch-Barrera, C. García-Franco, F. Guillen, M. Moreno-Jiménez, J. M. López-
Picazo, A. Gurpide, J. L. Perez-Gracia, J. Aristu, J. Garcia-Foncillas, I. Gil-Bazo
Brd. 23G The impact of PET imaging on outcomes in patients with stage III non-small
cell lung cancer (NSCLC) treated with chemoradiation: A subset analysis of
HOG LUN 01–24/USO-023. (Abstract #7065)
N. H. Jayaram, M. A. Neubauer, C. S. Johnson, T. Breen, C. E. Williams,
N. H. Hanna
Brd. 23H Role of surgery in patients with stage IIIA non-small cell lung cancer
(NSCLC): Lessons learned from a tertiary referral cancer center experience.
(Abstract #7066)
C. Aggarwal, B. Egleston, L. Li, H. Borghaei, R. Mehra, N. Somaiah, A. Turaka,
W. J. Scott, C. J. Langer, G. R. Simon
Brd. 24A Influence of surgical interventions on survival in patients with stage IIIb
non-small cell lung cancer (NSCLC): The Fox Chase Cancer Center (FCCC)
experience. (Abstract #7067)
W. J. Scott, C. Aggarwal, A. Lebenthal, B. Egleston, H. Borghaei, R. Mehra,
N. Somaiah, A. Turaka, G. R. Simon
Brd. 24B Surgeon-determined variability in quality of surgical resection of lung
cancer. (Abstract #7068)
R. A. Ramirez, A. Farooq, J. W. Allen, A. Berry, T. O’Brien, H. Cole,
R. U. Osarogiagbon
Brd. 24C Confirmation of the role of diabetes in the local recurrence of surgically
resected non-small cell lung cancer. (Abstract #7069)
A. Recht, J. M. Varlotto, L. N. Medford-Davis, E. Schaefer, J. C. Flickinger,
M. M. DeCamp
Brd. 24D Review of mediastinal lymph node examination (mLNE) in a lung cancer
resection (LCR) cohort. (Abstract #7070)
R. U. Osarogiagbon, J. W. Allen, A. Farooq, T. O’Brien, J. T. Wu
Brd. 24E Accuracy of endobronchial ultrasound-directed transbronchial needle
aspiration (EBUS-TBNA) for mediastinal staging in patients (pts) with
non-small cell lung cancer (NSCLC). (Abstract #7071)
M. G. Tupayachi, P. J. Hosein, D. M. Nguyen, R. T. Thurer, M. T. Garcia,
L. E. Raez, E. Donna
Brd. 24F Does the revised TNM staging system for lung cancer better estimate
actuarial rates of local/regional recurrence after surgery? (Abstract #7072)
J. M. Pepek, J. P. Chino, M. W. Onaitis, L. B. Marks, N. Ready, J. Crawford,
T. A. D’Amico, J. L. Hubbs, C. R. Kelsey
Brd. 24G Solitary pulmonary nodules (SPNs): Outcome of 6-year follow-up by a VA
multidisciplinary lung cancer group. (Abstract #7073)
H. B. Niell, J. P. Griffin, H. Cole, J. Salazar, D. Weiman, J. A. Kaufman, M. Zaman,
E. V. Thompson, N. Appling
Brd. 24H Examination of the influence that lymphatic and venous involvement gives
consequence of stage I non-small cell lung cancer in new TNM classification.
(Abstract #7074)
K. Kojima, N. Fujiwara, H. Arai
Brd. 25A Racial disparities on the use of invasive and noninvasive staging in patients
(pts) with non-small cell lung cancer (NSCLC). (Abstract #7075)
J. M. Suga, D. V. Nguyen, S. M. Mohammed, M. Brown, R. F. Calhoun,
K. Y. Yoneda, D. R. Gandara, P. Lara Jr.
Brd. 25B Survival of non-small cell lung cancer (NSCLC) patients in a randomized trial
as predicted by the FDG-PET standardized uptake value (SUV).
(Abstract #7076)
K. Y. Gulenchyn, T. Farncombe, D. E. Maziak, G. E. Darling, A. A. Driedger,
A. Hendler, C. Marriott, F. Raymond, L. Ehrlich, M. N. Levine
211
SUNDAY